BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Base editor correction of TERT promoter mutations for glioma

Claire Quang
April 1, 2020 5:42 PM UTC

INDICATION: Brain cancer...

BCIQ Company Profiles

Chinese Academy of Sciences

Zhejiang University School of Medicine

BCIQ Target Profiles

Telomerase reverse transcriptase (TERT)

BCIQ Company Profiles

Chinese Academy of Sciences

Zhejiang University School of Medicine

BCIQ Target Profiles

Telomerase reverse transcriptase (TERT)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS